Nimbus Therapeutics

Director/Senior Director, Nonclinical Safety (Toxicology)

Nimbus Therapeutics$225K — $285K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in Toxicology/Pathology or DVM with 10 years of pharmaceutical toxicology experience, or a Master's with 15 years.
  • Strong background in nonclinical GLP toxicology and safety assessment of small molecules.
  • Proven leadership skills in managing CRO relationships and quality oversight.
  • Deep understanding of GLP regulatory requirements and FDA communication.
  • DABT certification preferred but not mandatory.
  • Meticulous attention to detail with a focus on quality and compliance.
  • Excellent communication and organizational abilities to lead cross-functional projects.

Responsibilities

  • Develop strategic nonclinical toxicology plans in collaboration with stakeholders.
  • Collaborate with various departments to craft program-specific data generation strategies.
  • Represent Nonclinical Safety on cross-functional project teams.
  • Oversee the design and execution of toxicology studies aligned with company timelines.
  • Contribute to CMO selection and manage external consultants for nonclinical studies.
  • Efficiently govern CRO-managed safety studies through contract management and oversight.
  • Ensure completion of nonclinical safety studies on time and in alignment with corporate objectives.
  • Prepare documentation and respond to inquiries from the FDA regarding development programs.

Benefits

  • A collaborative work environment with cross-functional team engagement.
  • Opportunities for leadership and personal development in a dynamic setting.
  • Exposure to advanced GLP regulatory practices and protocols.
  • The chance to shape safety strategies for innovative small molecule drugs.
Full Job Description
Director/Senior Director, Nonclinical Safety

This role will lead the safety strategy, through both preclinical and clinical stages, and direct all phases of in vivo GLP and non-GLP toxicology studies, in collaboration with study teams, CROs and consultants. The person in this role will interface with various functional groups within the company and will report to our ED/VP of Nonclinical Safety.

In this role, you will:
  • Develop the strategic nonclinical toxicology development plan for programs in development in collaboration with stakeholders
  • Collaborate with CMC, Program & Portfolio Management, Clinical, Medical, and Regulatory Affairs to develop program-specific strategies for appropriate data generation in support of development candidate nomination, IND/CTA filing, and clinical development of new small molecule drug entities
  • Represent Nonclinical Safety at cross-functional project teams
  • Oversee the design and execution of safety pharmacology and toxicology studies (GLP and non-GLP) supporting preclinical and clinical development programs consistent with company timelines and goals
  • Contribute to the selection and management of consultants and CROs to support nonclinical safety studies for development programs
  • Manage nonclinical safety studies conducted by CROs with efficient governance including contract execution, authorization of study amendments, schedule and budget variance management, progress reporting to stakeholders, review of data and draft study reports, completion of contract milestones, study close-out and alignment of nonclinical safety evaluations with drug development efforts and priorities
  • Ensures completion of nonclinical safety studies to support Company timelines and goals
  • Respond to questions and prepare discussions documents for the FDA to in support of development programs.
  • Ensure compliance with global nonclinical toxicology and safety studies as per regulatory guidelines

These Qualifications Will Help This Role Be Successful
  • PhD in Toxicology/Pathology or DVM and approximately 10 years of toxicology experience in the pharmaceutical industry or Master's in Toxicology/Pathology or DVM and approximately 15 years of experience
  • Experience in nonclinical GLP toxicology and safety assessment of small molecules from discovery through regulatory submission
  • Strong leadership competencies and management experience, including selecting CROs and overseeing the quality of relationships
  • Demonstrated knowledge and full understanding of GLP regulatory requirements and providing responses to the FDA
  • DABT certification is preferred, but not required
  • Attention to detail quality and compliance
  • Excellent verbal and written communication and organizational skills required with demonstrated success in leading projects and interacting with cross functional teams
  • Ability to navigate, problem-solve, execute, and lead in a dynamic, fast-paced and evolving environment

Base salary range: $225,000 - $285,000

#LI-DNI

About Nimbus Therapeutics

Nimbus Therapeutics is a biotechnology company that develops small molecule therapies for a variety of diseases. The company was founded in 2009 by Bruce Booth and Jeb Keiper. Nimbus Therapeutics is headquartered in Cambridge, Massachusetts and has partnerships with several major pharmaceutical companies. The company's platform uses computational chemistry to design and develop small molecule drugs. Nimbus Therapeutics is focused on developing therapies for cancer, immunology, and metabolic diseases.
Learn more about Nimbus Therapeutics
Size
50 employees
Industry
Founded
2009

Similar Jobs

More Jobs at Nimbus Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Director/Senior Director, Nonclinical Safety (Toxicology) jobs: